Intellectual Property

  • May 07, 2026

    Google, Verizon Hit With IP Suits Over Auto-Reply Features

    Google and Verizon were hit with patent infringement suits in Texas federal court Wednesday over Google Pixel's Android Auto and Verizon's Driving Mode auto-reply features that send automated responses to incoming messages when hooked up to a vehicle's Bluetooth, which helps prevent distracted driving. 

  • May 07, 2026

    SAG-AFTRA Wants Out Of Singer's 'Furious 7' Royalties Suit

    The Screen Actors Guild-American Federation of Television and Radio Artists and its intellectual property rights distribution fund are seeking to escape a singer's lawsuit filed in California federal court claiming underpayment for his vocals in a song used in the film "Furious 7," arguing the claims are barred by federal law.

  • May 07, 2026

    Course Hero Operator Wants 'Whopping' $75M IP Verdict Cut

    The company behind academic file-sharing site Course Hero has asked a Connecticut federal judge for a new trial or to reduce the $75 million verdict it was hit with by a jury that found it had violated the Digital Millennium Copyright Act more than 3,000 times by manipulating documents belonging to Post University.

  • May 07, 2026

    Judge, In 'Difficult Position,' OKs Rare Patent Defense

    A Massachusetts federal judge found himself in what he said was a "difficult position" in allowing an unusual defense to be advanced in a patent infringement case related to blood pumps in light of criticism of the defense from the Federal Circuit.

  • May 07, 2026

    Netlist Backs DOJ Stance On Essential IP In Samsung Case

    The U.S. Department of Justice is correct that having a patent included in a standard does not necessarily give the patentholder market power, Netlist said in defending itself against Samsung's lawsuit accusing it of exploiting a standard-setting process.

  • May 07, 2026

    Womble Bond Atty's 'Draconian' Penalty Gives 4th Circ. Pause

    A Fourth Circuit panel seemed to struggle Thursday with what one judge described as a "draconian" contempt order against a Womble Bond Dickinson partner, with the panel nudging counsel for both sides toward a simpler solution that wouldn't force the court's involvement.

  • May 07, 2026

    Judge Knocks Out Pfizer Partner's Vax Case Against GSK

    A Delaware federal judge on Thursday threw out a suit seeking a finding that a drug developer that partnered with Pfizer and BioNTech on their COVID-19 vaccine didn't infringe drugmaker GlaxoSmithKline's patents.

  • May 07, 2026

    Conn. Investment Firm Settles $70M Client Poach Suit

    Connecticut investment firm TJT Capital Group LLC and its one-time chief compliance officer have settled a lawsuit accusing the former executive of taking 125 clients with $70 million in assets under management when he left for a new job, federal court records show.

  • May 07, 2026

    ZoomInfo Must Face Apollo Antitrust, False Ad Claims

    A Delaware federal judge has allowed Apollo.io to press ahead with most of its counterclaims against competitor ZoomInfo Technologies LLC, finding that Apollo plausibly alleged that its larger rival used monopoly power, patent litigation and negative customer messaging to suppress competition in the sales-intelligence data market.

  • May 07, 2026

    USPTO Tells Fed. Circ. Verizon Can't Appeal Ax Of IPR Win

    The U.S. Patent and Trademark Office has told the Federal Circuit that Verizon can't appeal a ruling by the agency's former director that wiped out the Patent Trial and Appeal Board's invalidation of a patent it challenged, saying the court has consistently upheld the board's ability to terminate such challenges.

  • May 07, 2026

    Gilead Accuses Pharmacies Of Selling Counterfeit HIV Drugs

    Gilead Sciences has sued several New York City pharmacies claiming they sold counterfeit HIV medication bearing the Gilead brand.

  • May 07, 2026

    Non-Nicotine Vape Maker Accuses Rival Of Patent Infringement

    Ready Mix Naturals LLC is suing a rival vape maker in Nevada federal court, alleging rival Globrands LLC and its subsidiaries are infringing Ready Mix's patents for non-nicotine vape products.

  • May 06, 2026

    Disney, James Cameron Sued Over Actress' 'Avatar' Likeness

    The Walt Disney Co. and director James Cameron used the likeness of indigenous actress Q'orianka Kilcher without her permission to create a main character in the blockbuster film "Avatar," a new California federal lawsuit claims.

  • May 06, 2026

    Ye Testifies In IP Suit That People 'Take Advantage' Of Him

    Ye took the stand on Wednesday to defend himself in a California copyright trial over whether early versions of his Grammy-winning hit "Hurricane" contained an unauthorized sound recording, saying that people try to "take advantage" of him despite him being "very generous" when it comes to giving artists their due.

  • May 06, 2026

    J&J, Tolmar Settle Patent Case Over Antipsychotic Drug

    A federal court Wednesday signed off on a consent judgment in a patent case brought by a Johnson & Johnson unit that prevents Tolmar Inc. from selling a generic version of the blockbuster schizophrenia drug Invega Sustenna.

  • May 06, 2026

    Trulieve Twists Patent Pleading Standard, Cannabis Co. Says

    A cannabis patent holder urged a Florida federal court to reject Trulieve Inc.'s effort to toss an infringement complaint, arguing that proof of its claims isn't needed when initially filing a lawsuit. 

  • May 06, 2026

    Igloo's Ads 'Uncool' But Not Unlawful, Split 9th Circ. Says

    It may have been "uncool" for ice chest company Igloo to wrongfully take credit for the first biodegradable cooler, but its claims are not unlawful under the Lanham Act, a split Ninth Circuit ruled Wednesday.

  • May 06, 2026

    Battery Patent Award Has Fed. Circ. Perusing Remand Options

    A Federal Circuit panel wrestled Wednesday with a Chinese battery cell manufacturer's challenge to the damages model supporting a competitor's award in a patent infringement case, with one judge asking if alternative calculations would even be available if the appeals court ordered a do-over.

  • May 06, 2026

    OpenSky Appeal In VLSI Dispute Postponed At Fed. Circ.

    The Federal Circuit has rescheduled arguments in OpenSky's challenge to an attorney fee award that was part of a wide-ranging patent dispute with VLSI Technology after OpenSky's attorney asked for a delay because of the sudden onset of an illness and the death of a family member.

  • May 06, 2026

    'You're In The Weeds!' Fed. Circ. Grapples With Gun IP Decision

    A Federal Circuit panel on Wednesday appeared perplexed by a Wyoming judge's decisions finding a firearm patent invalid as indefinite and dissolving a preliminary injunction against an accused infringer, saying the invalidity holding seemed to be at odds with precedent.

  • May 06, 2026

    Amazon Smart Devices Accused Of Infringing AI Co.'s Patents

    Artificial intelligence company Cerence AI on Wednesday accused Amazon of importing smart devices into the U.S. that violate its voice technology patents, asking the U.S. International Trade Commission to look into banning the devices, while also bringing a similar suit in federal court.

  • May 06, 2026

    Mr. America Owner Claims Bodybuilder Ripped Off Brand

    The company behind the Mr. America bodybuilding competition has sued a former bodybuilder, claiming he abruptly rebranded his entire company this year to start using the "Mr. America" mark.

  • May 06, 2026

    EDTX Urged To Deny Samsung New Trial After $78.5M Verdict

    A patent owner that won a $78.5 million infringement verdict in the Eastern District of Texas against Samsung urged the court to reject the electronics giant's bid for a new trial, saying the South Korean company wants to turn the law "on its head."

  • May 06, 2026

    Judge Won't Certify Minn. Fraud Question In Cancer Drug MDL

    A New Jersey federal judge won't ask the Supreme Court of Minnesota to weigh in on whether an insurer can pursue claims using a state law typically reserved for the attorney general in litigation alleging drugmaker Celgene used charitable donations to manipulate the price of cancer drugs.

  • May 06, 2026

    PTAB's Fast-Track Appeals Program Extended 2 Years

    A Patent Trial and Appeal Board program to resolve appeals of rejected patent applications faster will be extended through 2028, the board announced Wednesday.

Expert Analysis

  • Series

    Coaching Soccer Makes Me A Better Lawyer

    Author Photo

    Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.

  • Winter Olympics Put The Spotlight On IP Issues

    Author Photo

    This year's Winter Olympics generated a handful of intellectual property controversies that highlight the key considerations that should be kept in mind when using creative works at sporting events, says attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: The Human Element

    Author Photo

    Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.

  • Avoid The Unexpected When Drafting License Agreements

    Author Photo

    The Delaware Court of Chancery's recent decision in Commave v. Zevrain raises several practice points for attorneys drafting commercial contracts, underscoring the importance of considering anti-assignment provisions, specific exclusions and potential carveouts when drafting license agreements or other commercial contracts, say attorneys at Hogan Lovells.

  • A Reliable Liability Shield For Government-Sponsored R&D

    Author Photo

    The Federal Circuit's decision in Arlton v. AeroVironment last month confirms that the Section 1498 liability-shifting framework applies well beyond production contracts, providing powerful assurance that contractors performing government-directed work are shielded from patent infringement liability, say attorneys at Morgan Lewis.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • Have Iconic Twitter Trademarks Been Abandoned?

    Author Photo

    A set of lawsuits concerning the status of X Corp.'s "Twitter" and "tweet" trademarks, which will potentially be considered abandoned in July, will provide instructive insights into how trademark owners can defend against abandonment claims, say attorneys at Bradley Arant.

  • Google's Scraping Suit Asks How Far DMCA Protections Go

    Author Photo

    A California federal court's decision in Google v. SerpApi will spotlight a long-developing judicial split over how to apply the Digital Millennium Copyright Act’s ban on circumventing a copyright holder’s access controls, an increasingly important point in litigation over web scraping and artificial intelligence training, say attorneys at Jenner & Block.

  • Trial Advocacy Lessons From 3 Oscar-Nominated Films

    Author Photo

    Several films up for best picture at this weekend’s Academy Awards provide useful tips for trial lawyers, from the power of a dramatic opening to the importance of pivoting when the unexpected happens, say attorneys at Robins Kaplan.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • Patent Eligibility Bulletin: Steps To Consider As USPTO Shifts

    Author Photo

    Recent memoranda from the U.S. Patent and Trademark Office, along with some of the first patents issued under Director John Squires, indicate a recalibration of the subject matter eligibility landscape, signaling a renewed emphasis on concrete technological improvements and a potentially pro-AI stance, say attorneys at Banner Witcoff.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • Why La. Ruling May Open NIL Deals For Int'l Student-Athletes

    Author Photo

    A Louisiana federal court's decision to deny a motion to dismiss in Poa v. Jaddou, a case over whether international student-athletes may engage in name, image and likeness deals, signals that courts are willing to challenge rigid interpretations of immigration law in light of modern collegiate athletics, say attorneys at Shook Hardy.

  • Weighing Confusion Claims In Shoes-NFL Steakhouse TM Suit

    Author Photo

    A recent New York federal infringement complaint by 1587 Sneakers against Patrick Mahomes and Travis Kelce's Kansas City steakhouse 1587 Prime confronts the thorny question of how much operating in different industries should factor into likelihood-of-confusion analysis and why consumer perception can matter most in trademark fights, says Nate Garhart at Spencer West.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.